Skip to main content
    N

    Neuphoria Therapeutics Inc (NEUP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.39
    +0.07 (+2.11%)

    Market Cap: $17.53M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    71%(12/17)
    Avg Surprise
    -312.54%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$N/A
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-N/A---
    Sep 26EST
    		-N/A---
    Jun 26
    Reported Sep 2
    		$-0.13N/A+76.79%Beat+97.7%
    Mar 26
    Reported May 15
    		$-0.09N/A+83.93%Beat-101.4%
    Dec 25
    Reported Feb 17
    		$0.41$-0.56+173.21%Beat+133.2%
    Sep 25
    Reported Nov 14
    		$-4.41$-1.31-236.64%Miss-129605.9%
    Jun 25
    Reported Sep 29
    		$-5.55$-3.83-44.91%Miss-12600.2%
    Mar 25
    Reported May 20
    		$6.55$6.44+1.71%Beat+119.3%
    Dec 24
    Reported Mar 17
    		$-1.23$0.00N/ABeat-93.5%
    Sep 24
    Reported Nov 14
    		$-0.00N/AN/ABeat-
    Jun 24
    Reported Aug 21
    		$-0.04N/A+93.39%Beat-
    Mar 24
    Reported May 29
    		$-33.98$-0.58-5758.98%Miss-
    Dec 23
    Reported Mar 30
    		$-0.64$-0.63-1.19%Miss+4.0%
    Sep 23
    Reported Nov 29
    		$0.00N/A+100.00%Beat+100.0%
    Jun 23
    Reported Aug 23
    		$0.00N/A+100.00%Beat+100.0%
    Mar 23
    Reported May 31
    		$0.00N/A+100.00%Beat+100.0%
    Dec 22
    Reported Feb 22
    		$-0.66$-0.66-0.64%Miss-30.2%
    Sep 22
    Reported Nov 30
    		$-0.70$-0.70+0.11%Beat+13.6%
    Jun 22
    Reported Aug 25
    		$-97.20$-97.20+0.00%Beat-
    Mar 22
    Reported Jun 1
    		$-102.60$-102.60+0.00%Beat-
    Dec 21
    Reported Feb 22
    		$-0.51$-0.51+0.00%Beat-
    Sep 21
    Reported Dec 1
    		$-0.81$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-0.80EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin-15.70%
    ROE-61.70%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio27.85xQuick Ratio27.85x
    Trading Statistics
    BetaN/AAvg Volume13.09K
    52-Week High$17.1952-Week Low$3.19

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.43
    SMA 20$3.55
    SMA 50$3.72
    SMA 200$4.20
    EMA 10$3.43
    EMA 20$3.52
    EMA 50$3.69
    EMA 200$4.46

    MACD

    Line: -0.11Signal: -0.09Hist: -0.02

    ADX

    ADX: 24.7+DI: 16.6-DI: 22.3

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$3.32

    Bollinger Bands

    Upper Band$3.84
    Lower Band$3.27
    %B Position1617%(Upper)
    Band Width0.21

    RSI (14-Day)

    Neutral
    30.6

    Momentum Oscillators

    Stoch %K9.1
    Stoch %D6.0
    Williams %R-81.6
    ROC (10d)-5.0%
    Momentum-0.18
    CCI (20d)-88.2
    MFI (14d)18.9

    Volatility Measures

    ATR (14d)$0.09(2.8%)
    StdDev (20d)0.14
    Hist Vol15.7%(Low)

    Volume Flow

    VWAP$3.40
    OBV85.2M
    AD Line-57.0M
    CMF (20d)-0.612

    Volume Metrics

    Avg Vol (20d)12.9K
    Vol Ratio2.1x(High)
    VWMA (20d)$3.56

    Pivot Points

    R3$3.42
    R2$3.40
    R1$3.36
    Pivot Point$3.34
    S1$3.30
    S2$3.28
    S3$3.24

    Advanced Oscillators

    TSI-46.64
    Ultimate Osc27.2
    KST-87.41

    Financial Data

    QuarterMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Mar 2023
    Total Revenue$0$0$0$-13,267$15.00M$662,715$0$0$0$0$0$-44,717
    Cost of Revenue$0$165,789$0$7.98M$0$0$0$165,685$0$0$0$3.62M
    Gross Profit$0$-165,789$0$-13,267$15.00M$662,715$0$-165,685$0$0$0$3.58M
    Operating Expenses$1.21M$6.08M$5.65M$5.82M$3.02M$4.37M$5.65M$5.48M$2.39M$4.55M$5.47M$7.37M
    R&D$-518,168$1.05M$3.79M$3.75M$1.62M$1.74M$3.79M$3.10M$1.20M$2.03M$3.09M$2.94M
    SG&A$1.69M$3.19M$1.87M$2.07M$1.41M$2.63M$1.87M$2.38M$1.20M$2.52M$2.38M$3.10M
    Operating Income$-1,211,649$-6,083,503$-5,652,689$-5,835,046$11.98M$-3,703,511$-5,652,689$-5,477,876$-2,394,031$-4,552,862$-5,467,607$-11,040,127
    Interest Income$186,171$167,311$141,996$87,046$12,741$30,615$141,996$26,327$52,615$54,716$86,439$0
    Interest Expense$0$0$6.49M$3.32M$796,218$0$4.29M$0$367,734$36,356$39,754$0
    Income Before Tax$-539,856$2.74M$-9,941,297$-9,150,259$11.18M$-1,931,740$-9,941,297$-2,721,142$-2,761,765$-4,589,218$-5,507,361$-5,314,821
    Income Tax Expense$-34,793$-52,124$-34,793$-266,602$-81,186$11,609$-34,793$-34,116$16,383$-34,794$-34,793$34,894
    Net Income$-505,063$2.79M$-9,906,504$-8,883,657$11.26M$-1,943,349$-9,906,504$-2,687,026$-2,778,148$-4,554,424$-5,472,568$-5,279,926
    EBITDA$-726,027N/A$-8,301,126$38,543$11.33M$1.83M$-807,357$-2,583,419$-2,648,677$-4,478,240$-5,426,256$-5,681,542
    EBIT$-726,027N/A$-8,551,952$-127,082$11.17M$1.66M$-973,070$-2,749,104$-2,814,380$-4,643,934$-5,592,165$-5,837,171
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NEUP

    News

    Neuphoria Therapeutics Inc. (NEUP) Stock Price, News, Quote & History

    This article provides a real-time stock quote and essential company information for Neuphoria Therapeutics Inc. (NEUP) from Yahoo Finance. It displays the current stock price, recent performance...

    Yahoo! Finance Canada•10/5/26•Neutral

    NEUP Stock Price and Chart — NASDAQ:NEUP

    This article provides a detailed overview of Neuphoria Therapeutics Inc. (NEUP) stock, including its current price, market capitalization, financial performance...

    TradingView•9/18/26•Bearish

    Neuphoria Therapeutics Inc. FY 2026: Revenue $1.17M, Net loss $13.59M — 10-K Summary

    Neuphoria Therapeutics Inc. reported significantly reduced revenue of $1.17M and a wider net loss of $13.59M for fiscal year 2026...

    TradingView•9/18/26•Bearish

    Neuphoria Therapeutics Inc (NEUP) Earnings Forecast: Future EPS & Revenue Growth Estimates

    Neuphoria Therapeutics Inc (NEUP) has an earnings forecast score of 6.00, placing it 327 out of 385 in the Biotechnology & Medical Research industry. Analysts have set an average price target of $20.00 for NEUP...

    TradingKey•8/7/26•Somewhat-Bullish

    Are CBZ, SAFT, NEUP, TCBK Obtaining Fair Deals for their Shareholders?

    Halper Sadeh LLC, an investor rights law firm, is investigating CBIZ, Inc. (CBZ), Safety Insurance Group Inc. (SAFT), Neuphoria Therapeutics Inc. (NEUP)...

    PR Newswire•8/4/26•Somewhat-Bearish

    NEUP Valuation and Fair Value

    P/E
    -0.8x
    P/B
    0.6x
    See GNG's fair value

    NEUP Profitability: Margins, ROIC and FCF

    Operating margin
    -15.7%
    Net margin
    0.0%
    ROE
    -61.7%

    NEUP Competitors

    CompanyTicker
    ReWalk Robotics LtdLFWD
    Quantum BioPharma Ltd.QNTM
    Retractable Technologies IncRVP
    Jasper Therapeutics IncJSPR
    Sensei Biotherapeutics IncSNSE
    Dyadic International IncDYAI
    Akari Therapeutics PLCAKTX
    Concord Medical Services HoldingsCCM

    Sector: Healthcare

    NEUP Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    21.1%

    Frequently Asked Questions About NEUP

    Does NEUP pay dividends?

    Neuphoria Therapeutics Inc (NEUP) does not currently pay a regular dividend.

    What is NEUP's market cap?

    Neuphoria Therapeutics Inc (NEUP) has a market capitalization of $17.53M with a current stock price of $3.39.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In